Cargando…
Arginine, glycine, aspartic acid peptide-modified paclitaxel and curcumin co-loaded liposome for the treatment of lung cancer: in vitro/vivo evaluation
PURPOSE: In this study, a novel arginine, glycine, aspartic acid peptide (RGD)-modified paclitaxel and curcumin co-loaded liposomes were developed to evaluate their antitumor activity in vitro and in vivo. MATERIALS AND METHODS: Co-loaded liposomes were prepared using the solvent evaporation method....
Autores principales: | Jiang, Kanqiu, Shen, Mingjing, Xu, Weihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927341/ https://www.ncbi.nlm.nih.gov/pubmed/29731631 http://dx.doi.org/10.2147/IJN.S157746 |
Ejemplares similares
-
Antilung cancer effect of ergosterol and cisplatin-loaded liposomes modified with cyclic arginine-glycine-aspartic acid and octa-arginine peptides
por: Wu, Meijia, et al.
Publicado: (2018) -
Evaluation of the Biodistribution of Arginine, glycine, aspartic acid peptide-modified Nanoliposomes Containing Curcumin in Rats
por: Salehi Najafabadi, Parisa, et al.
Publicado: (2022) -
A dual-targeting liposome conjugated with transferrin and arginine-glycine-aspartic acid peptide for glioma-targeting therapy
por: QIN, LI, et al.
Publicado: (2014) -
Arginine-Glycine-Aspartic Acid-anchored Curcumin-based Nanotherapeutics Inhibit Pyroptosis-induced Cytokine Release Syndrome for In Vivo and In Vitro Sepsis Applications
por: Shi, Yi, et al.
Publicado: (2023) -
Cyclic arginine-glycine-aspartic acid-modified red blood cells for drug delivery: Synthesis and in vitro evaluation
por: Wang, Chen, et al.
Publicado: (2022)